During the past decade, Ospedale Oncologico A. Businco conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 14 clinical trials were completed, i.e. on average, 26.9% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 2 clinical trials were completed. i.e. 9.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Oncologico A. Businco" #1 sponsor was "Fondazione Italiana Linfomi ONLUS" with 17 trials, followed by "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 14 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials sponsored and "Heart Care Foundation" with 4 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Oncologico A. Businco" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 6 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 3 trials as a collaborator, "ADIR, a Servier Group company" with 2 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 2 trials as a collaborator and "Istituto Di Ricerche Farmacologiche Mario Negri" with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Oncologico A. Businco" are "Leukemia" (5 trials), "Chronic Lymphocytic Leukemia" (4 trials), "Myelodysplastic Syndromes" (4 trials), "Coronary Artery Disease" (3 trials) and "Acute Myeloid Leukemia" (2 trials). Many other conditions were trialed in "Ospedale Oncologico A. Businco" in a lesser frequency.

Most popular intervention types in "Ospedale Oncologico A. Businco" are "Drug" (74 trials), "Other" (13 trials), "Procedure" (12 trials), "Device" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Rituximab" (7 trials), "etoposide" (4 trials), "Deferasirox" (3 trials) and "Ibrutinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Oncologico A. Businco" are 102 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Oncologico A. Businco". undefined are not yet recruiting, 18 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Ospedale Oncologico A. Businco, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Oncologico A. Businco, 1 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".